Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade
Publication type: Journal Article
Publication date: 2022-04-12
scimago Q1
wos Q1
SJR: 1.200
CiteScore: 10.3
Impact factor: 4.6
ISSN: 13543776, 17447674
PubMed ID:
35410559
Drug Discovery
General Medicine
Pharmacology
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
7
|
|
|
Molecules
7 publications, 24.14%
|
|
|
Journal of Medicinal Chemistry
3 publications, 10.34%
|
|
|
International Journal of Molecular Sciences
2 publications, 6.9%
|
|
|
Advances in Pharmacology
2 publications, 6.9%
|
|
|
Results in Chemistry
1 publication, 3.45%
|
|
|
Mendeleev Communications
1 publication, 3.45%
|
|
|
Process Biochemistry
1 publication, 3.45%
|
|
|
ACS Medicinal Chemistry Letters
1 publication, 3.45%
|
|
|
Immunity, inflammation and disease
1 publication, 3.45%
|
|
|
International Journal of Biological Macromolecules
1 publication, 3.45%
|
|
|
Drug Metabolism and Disposition
1 publication, 3.45%
|
|
|
Inhalation Toxicology
1 publication, 3.45%
|
|
|
Journal of Food Bioactives
1 publication, 3.45%
|
|
|
Invention Disclosure
1 publication, 3.45%
|
|
|
Current Issues in Molecular Biology
1 publication, 3.45%
|
|
|
In Silico Research in Biomedicine
1 publication, 3.45%
|
|
|
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 3.45%
|
|
|
Future Medicinal Chemistry
1 publication, 3.45%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 3.45%
|
|
|
1
2
3
4
5
6
7
|
Publishers
|
2
4
6
8
10
|
|
|
MDPI
10 publications, 34.48%
|
|
|
Elsevier
9 publications, 31.03%
|
|
|
American Chemical Society (ACS)
4 publications, 13.79%
|
|
|
Taylor & Francis
3 publications, 10.34%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 3.45%
|
|
|
Wiley
1 publication, 3.45%
|
|
|
International Society for Nutraceuticals & Functional Foods (ISNFF)
1 publication, 3.45%
|
|
|
2
4
6
8
10
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
29
Total citations:
29
Citations from 2025:
8
(27.59%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Iyer M. R., Kundu B., Wood C. M. Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade // Expert Opinion on Therapeutic Patents. 2022. Vol. 32. No. 6. pp. 629-647.
GOST all authors (up to 50)
Copy
Iyer M. R., Kundu B., Wood C. M. Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade // Expert Opinion on Therapeutic Patents. 2022. Vol. 32. No. 6. pp. 629-647.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/13543776.2022.2054329
UR - https://doi.org/10.1080/13543776.2022.2054329
TI - Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade
T2 - Expert Opinion on Therapeutic Patents
AU - Iyer, Malliga R.
AU - Kundu, Biswajit
AU - Wood, Casey M
PY - 2022
DA - 2022/04/12
PB - Taylor & Francis
SP - 629-647
IS - 6
VL - 32
PMID - 35410559
SN - 1354-3776
SN - 1744-7674
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Iyer,
author = {Malliga R. Iyer and Biswajit Kundu and Casey M Wood},
title = {Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade},
journal = {Expert Opinion on Therapeutic Patents},
year = {2022},
volume = {32},
publisher = {Taylor & Francis},
month = {apr},
url = {https://doi.org/10.1080/13543776.2022.2054329},
number = {6},
pages = {629--647},
doi = {10.1080/13543776.2022.2054329}
}
Cite this
MLA
Copy
Iyer, Malliga R., et al. “Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade.” Expert Opinion on Therapeutic Patents, vol. 32, no. 6, Apr. 2022, pp. 629-647. https://doi.org/10.1080/13543776.2022.2054329.